113 related articles for article (PubMed ID: 30142549)
1. Effects of acute olanzapine exposure on central insulin-mediated regulation of whole body fuel selection and feeding.
Castellani LN; Wilkin J; Abela AR; Benarroch L; Ahasan Z; Teo C; Wilson V; Kowalchuk C; Giacca A; Remington GJ; Hahn MK
Psychoneuroendocrinology; 2018 Dec; 98():127-130. PubMed ID: 30142549
[TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents.
Albaugh VL; Vary TC; Ilkayeva O; Wenner BR; Maresca KP; Joyal JL; Breazeale S; Elich TD; Lang CH; Lynch CJ
Schizophr Bull; 2012 Jan; 38(1):153-66. PubMed ID: 20494946
[TBL] [Abstract][Full Text] [Related]
3. Effects of intracerebroventricular (ICV) olanzapine on insulin sensitivity and secretion in vivo: an animal model.
Hahn MK; Chintoh A; Remington G; Teo C; Mann S; Arenovich T; Fletcher P; Lam L; Nobrega J; Guenette M; Cohn T; Giacca A
Eur Neuropsychopharmacol; 2014 Mar; 24(3):448-58. PubMed ID: 24001874
[TBL] [Abstract][Full Text] [Related]
4. In male rats, the ability of central insulin to suppress glucose production is impaired by olanzapine, whereas glucose uptake is left intact.
Kowalchuk C; Teo C; Wilson V; Chintoh A; Lam L; Agarwal SM; Giacca A; Remington GJ; Hahn MK
J Psychiatry Neurosci; 2017 Nov; 42(6):424-431. PubMed ID: 29083297
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system delivery of the antipsychotic olanzapine induces hepatic insulin resistance.
Martins PJ; Haas M; Obici S
Diabetes; 2010 Oct; 59(10):2418-25. PubMed ID: 20682682
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotics differentially regulate insulin, energy sensing, and inflammation pathways in hypothalamic rat neurons.
Kowalchuk C; Kanagasundaram P; Belsham DD; Hahn MK
Psychoneuroendocrinology; 2019 Jun; 104():42-48. PubMed ID: 30802709
[TBL] [Abstract][Full Text] [Related]
7. Prevention of the adverse effects of olanzapine on lipid metabolism with the antiepileptic zonisamide.
Stefanidis A; Watt MJ; Cowley MA; Oldfield BJ
Neuropharmacology; 2017 Sep; 123():55-66. PubMed ID: 28400260
[TBL] [Abstract][Full Text] [Related]
8. Second-generation antipsychotics cause a rapid switch to fat oxidation that is required for survival in C57BL/6J mice.
Klingerman CM; Stipanovic ME; Bader M; Lynch CJ
Schizophr Bull; 2014 Mar; 40(2):327-40. PubMed ID: 23328157
[TBL] [Abstract][Full Text] [Related]
9. Phoenixin-14 injected intracerebroventricularly but not intraperitoneally stimulates food intake in rats.
Schalla M; Prinz P; Friedrich T; Scharner S; Kobelt P; Goebel-Stengel M; Rose M; Stengel A
Peptides; 2017 Oct; 96():53-60. PubMed ID: 28844870
[TBL] [Abstract][Full Text] [Related]
10. A role of neuropeptide CART in hyperphagia and weight gain induced by olanzapine treatment in rats.
Nakhate KT; Subhedar NK; Kokare DM
Brain Res; 2018 Sep; 1695():45-52. PubMed ID: 29775565
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotics impair regulation of glucose metabolism by central glucose.
Castellani LN; Pereira S; Kowalchuk C; Asgariroozbehani R; Singh R; Wu S; Hamel L; Alganem K; Ryan WG; Zhang X; Au E; Chintoh A; Remington G; Agarwal SM; Giacca A; Mccullumsmith RE; Hahn MK
Mol Psychiatry; 2022 Nov; 27(11):4741-4753. PubMed ID: 36241692
[TBL] [Abstract][Full Text] [Related]
12. Chronic central leptin decreases food intake and improves glucose tolerance in diet-induced obese mice independent of hypothalamic malonyl CoA levels and skeletal muscle insulin sensitivity.
Keung W; Palaniyappan A; Lopaschuk GD
Endocrinology; 2011 Nov; 152(11):4127-37. PubMed ID: 21914780
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of central leptin and resistin on body weight, insulin resistance, and beta-cell function and mass by the modulation of hypothalamic leptin and insulin signaling.
Park S; Hong SM; Sung SR; Jung HK
Endocrinology; 2008 Feb; 149(2):445-54. PubMed ID: 17991727
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats.
Choi S; DiSilvio B; Unangst J; Fernstrom JD
Life Sci; 2007 Sep; 81(12):1024-30. PubMed ID: 17822717
[TBL] [Abstract][Full Text] [Related]
15. Early perturbation in feeding behaviour and energy homeostasy in olanzapine-treated rats.
Victoriano M; Hermier D; Even PC; Fromentin G; Huneau JF; Tomé D; de Beaurepaire R
Psychopharmacology (Berl); 2009 Sep; 206(1):167-76. PubMed ID: 19572122
[TBL] [Abstract][Full Text] [Related]
16. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.
Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ
Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121
[TBL] [Abstract][Full Text] [Related]
17. Elevation of systolic blood pressure in an animal model of olanzapine induced weight gain.
Patil BM; Kulkarni NM; Unger BS
Eur J Pharmacol; 2006 Dec; 551(1-3):112-5. PubMed ID: 17046744
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine effects on body composition, food preference, glucose metabolism and insulin sensitivity in the rat.
Smith GC; Vickers MH; Shepherd PR
Arch Physiol Biochem; 2011 Oct; 117(4):241-9. PubMed ID: 21671852
[TBL] [Abstract][Full Text] [Related]
19. The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance.
Lykkegaard K; Larsen PJ; Vrang N; Bock C; Bock T; Knudsen LB
Schizophr Res; 2008 Aug; 103(1-3):94-103. PubMed ID: 18579346
[TBL] [Abstract][Full Text] [Related]
20. Chronic olanzapine administration in rats: effect of route of administration on weight, food intake and body composition.
Mann S; Chintoh A; Giacca A; Fletcher P; Nobrega J; Hahn M; Remington G
Pharmacol Biochem Behav; 2013 Feb; 103(4):717-22. PubMed ID: 23234835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
